Also trades as: PEARW (NASDAQ) · $vol 0M
PEAR NASDAQ
Pear Therapeutics, Inc.
1W: -43.2%
1M: -70.0%
3M: -99.5%
1Y: -99.9%
$0.03
Last traded 2023-05-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$13M
Revenue
+201.7% YoY
$25M
Net Income
+127.0% YoY
$-117M
Free Cash Flow
-7.6% YoY
32.0%
Gross Margin
-1136.8%
Op. Margin
1123.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE40.9%
ROA17.0%
ROIC-1092.4%
Valuation
P/E-0.2
P/B0.1
EV/EBITDA-0.8
Leverage
Debt/Equity1.23
Current Ratio1.48
Interest Cov.-13.4x
Quality Scores
Piotroski F4/9
Altman Z-5.25
Beneish M8.39